Novartis has committed another $1.7 billion to its ambition to become a kidney disease leader. The Swiss drugmaker is making ...

An approval decision for Stealth BioTherapeutics’ investigational treatment for an ultra-rare genetic disease has been ...

Parkinson’s disease has always been a complex puzzle, for patients and researchers alike, with contributing factors ranging ...

Pink slips have followed the green light at Entrada Therapeutics. | Pink slips have followed the green light at Entrada ...

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...

Ono Pharma’s U.S. arm is laying off 83 staffers at its site in Cambridge, Massachusetts. | The affected Cambridge site is Ono ...

Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of ...